$2.09
-3.02%
2026-09-04 10:40:58 EDT-$0.06
기술
정보 기술 서비스
NYSE
활발히 거래 중
Clarivate Plc는 구조화된 데이터와 인사이트를 제공하는 저명한 정보 서비스 및 분석 기업으로서 활동한다. 그 핵심 임무는 과학 연구, 혁신 및 확립된 브랜드의 ...
Clarivate Plc는 구조화된 데이터와 인사이트를 제공하는 저명한 정보 서비스 및 분석 기업으로서 활동한다. 그 핵심 임무는 과학 연구, 혁신 및 확립된 브랜드의 ...
Clarivate Plc (NYSE: CLVT) is a global provider of “transformative intelligence,” combining high-value data with analytics and workflow solutions for customers such as academia, government, law firms, and life sciences organizations. The company’s services are designed to help users move from discovery to execution—supporting how research is planned, funded, conducted, evaluated, and translated into real-world impact. From a business perspective, Clarivate operates across several interconnected domains: - Scholarly and research intelligence: Clarivate offers the Web of Science suite and related tools including InCites and Journal Citation Reports for research discovery, performance evaluation, and analytics. It also provides workflow and publishing support tools such as EndNote, ScholarOne, Converis, and related platforms. - Life sciences decision support: In this area, products such as Cortellis and Newport Integrity are aimed at helping pharmaceutical and biotechnology organizations monitor competitive landscapes, assess market intelligence, and support development and launch planning. - Intellectual property (IP) management: The Derwent product line—covering Derwent Innovation, Techstreet, and IP Professional Services—supports customers in evaluating originality, establishing freedom-to-operate boundaries, securing and analyzing patent protection, and understanding the competitive technological landscape. - Trademark and digital brand protection: Clarivate includes solutions such as CompuMark (trademark screening/search/monitoring) and MarkMonitor (helping enterprises manage and strengthen their digital presence). Product-wise, Clarivate’s approach typically involves enriching and organizing large-scale datasets and then packaging them into usable workflows—so customers can reduce manual effort, improve decision quality, and ensure better compliance across research, IP, and brand processes. The company’s offerings span the entire research and innovation lifecycle: from literature discovery and citation intelligence to IP analytics and operational support for commercialization. Cost and delivery model considerations: Clarivate is largely software- and data-enabled, so revenue is generally supported by subscription-style access and enterprise licensing, with expert or service elements layered in where domain expertise is required (for example, in research evaluation and IP-related work). Because its “assets” are information systems, content/data enrichment pipelines, and analytics models, the cost structure often emphasizes platform development, content acquisition/enrichment, and ongoing customer support. Financially, available market data for CLVT indicates a publicly traded profile with ongoing investment in operations; however, detailed unit economics (e.g., BOM-like breakdown) are not publicly provided in the supplied inputs. In general terms for the sector, major drivers include data processing and curation, cloud/IT infrastructure, and sales/CS costs for enterprise contracts. Key people: Clarivate’s CEO is Matti Shem Tov (appointed as the company’s next CEO per the provided press-release information). Strategically, the company aligns product roadmaps around expanding data coverage, improving analytics/workflows, and strengthening domain-specific solutions for life sciences and IP. Wishes/forward outlook (consistent with the company’s mission): customers typically want more complete and timely coverage, faster workflow enablement, better integration into existing research and legal operations, and improved transparency/traceability of the intelligence used for decisions. Clarivate’s stated mission—discovery, protection, and commercialization of research, innovations, and established brands—directly aligns with those priorities.